🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨 Last Chance to Apply! 🚨 Elevate your career with the NDARC Postgrad Term Three Intake! Applications close on 9 May 2025, 12.00 AM (AEST). Apply now! #NDARC #Postgrad #TermThreeIntake #DeadlineApproaching

New research from NCCRED points to "substantial interest" in integration support following naturalistic psychedelic experiences among people with substance use concerns. Read more: akjournals.com/view/journals/…

Registrations are now open for the 2025 NDARC Annual Research Symposium! The event will bring together leading experts to explore the latest developments in #AOD research. Keynote speakers & full program to be revealed soon. Register for free here: unsw.edu.au/research/ndarc…

Join Associate Professor Sally Nathan from UNSW to learn about the experiences of young people referred to #AOD treatment, including a focus on mortality, hospitalisations and convictions data. 🗓️ Thurs, 8 May ⏲️ 3pm AEST 📍 Zoom Register here: us06web.zoom.us/webinar/regist…

In the latest Drug Trends bulletin, survey results show hydroponic and bush cannabis were the most commonly used forms of #cannabis among people who regularly use illicit drugs, with smoking the most common route of administration. Read more: unsw.edu.au/research/ndarc… #AOD

More Australians are overdosing on gamma hydroxybutyrate - better known as #GHB. NCCRED researchers wrote about what people can do to reduce their risk of a GHB overdose for The Conversation - Australia + New Zealand. Read more here: theconversation.com/more-australia…

Did you miss our webinar with Dr Ashlea Bartram (from NCETA) about how exposure to zero-alcohol drinks and advertisements affects adolescents’ perceptions of full-strength #alcohol products? Watch the recording here: unsw.edu.au/research/ndarc… #AOD

Congratulations to NDARC's Scientia Professor Louisa Degenhardt, who has been awarded a $2.3 million NHMRC grant to address the serious health and social challenges for people who have been incarcerated. Read more here: unsw.edu.au/news/2025/05/n…

The May 2025 edition of the NDARC newsletter is out now. Catch up on the latest news and events in the #AOD sector. Read here: us4.campaign-archive.com/?u=90d6d818395…

"It's a highly misunderstood drug." NCCRED researcher Dr Krista Siefried was one of the experts interviewed about methamphetamine for the 'Science Vs' podcast series. You can listen to the full episode here: podcasts.apple.com/au/podcast/met… #AOD

The risk of lethal toxicity 'remains relatively low' among people prescribed lithium as a mood stabiliser, NDARC-led researchers report in a study of coronial cases. Read more here: journals.sagepub.com/doi/full/10.11… #AOD

Did you miss our webinar with Associate Professor Sally Nathan about the experiences of young people referred to alcohol and other drugs #AOD treatment? Watch the recording here: unsw.edu.au/research/ndarc…

"The evidence from this study represents a major step forward in what we know about the safety of smoking cessation pharmacotherapies during pregnancy." NDARC's Dr Alys Havard & Dr Duong Tran wrote about their research for MJA InSight+. Read more here: insightplus.mja.com.au/2025/18/reassu…

Join NDARC's Prof Rebecca McKetin & the Tina Trial team to learn about their experience conducting the world-first phase 3 trial of mirtazapine treatment for methamphetamine use disorder. 🗓️ Thurs, 22 May ⏲️ 3pm AEST 📍 Zoom webinar Register here: us06web.zoom.us/webinar/regist… #AOD

Most people who inject drugs in Aus were part of a cohort that began injecting in the 80s & 90s, NDARC research shows This suggests that healthcare provision for this group "must consider the effects of ageing" & long-term injecting drug use. Read more: thelancet.com/journals/lanwp…

🚨FINAL CALL🚨 Have you registered for this week's special edition webinar with Prof Rebecca McKetin? Sign up now for a behind-the-scenes look at the world-first Tina Trial, which tested mirtazapine for methamphetamine use disorder. Register here: us06web.zoom.us/webinar/regist… #AOD

Join Oisin Stronach from the Burnet Institute to learn about how Gen X are the most at-risk cohort for #methamphetamine-related deaths in Australia. 🗓️ Thursday, 29 May ⏲️ 3pm AEST 📍 Zoom webinar Register here: us06web.zoom.us/webinar/regist… #AOD

Congratulations to Odyssey House NSW for another successful Odyssey Women's Lunch! NDARC's Professor Michael Farrell, Nicolas Parkhill & Dr Michala Kowalski were delighted to attend the event in support of families impacted by #AOD use issues.

"We always talk about timing, dosing and measuring, and not mixing #GHB with other drugs that can slow down your central nervous system." NCCRED's Dr Jack Freestone spoke about GHB harm reduction strategies with JOY Media. Listen to the interview here: joy.org.au/joydrive/2025/…

Did you miss our special edition webinar with Professor Rebecca McKetin and the Tina Trial team about their experience conducting the world-first phase 3 trial of mirtazapine treatment for #methamphetamine use disorder? Watch the recording here: unsw.edu.au/research/ndarc… #AOD